Frazier Life Sciences Management, L.P. TRVI Holdings History
Frazier Life Sciences Management, L.P.'s Trevi Therapeutics Inc Holding Summary
As of 2025-03-31, Frazier Life Sciences Management, L.P. held 10.26 Mil shares of Trevi Therapeutics Inc(TRVI), totaling $64.53 Mil. This investment constitutes 2.95% of their stock portfolio, and Frazier Life Sciences Management, L.P. now holds 10.08% of the outstanding Trevi Therapeutics Inc(TRVI) stock.
The initial trade took place in 2022Q2. And since then Frazier Life Sciences Management, L.P. has made 6 purchases of TRVI, at an average price of $2.91, for a total of 10.66 Mil shares. In addition, there have been 1 sales at an average price of $4.77 for 405,365.00 shares. Based on historical transaction data and TRVI's current price of $7.76, Frazier Life Sciences Management, L.P.'s estimated gain on his TRVI holdings is $50.44 Mil, reflecting a 162.43% gain to date.
Frazier Life Sciences Management, L.P. TRVI ($7.76) Holding Chart
Frazier Life Sciences Management, L.P. TRVI ($7.76) Quarterly Buys and Sells
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
|---|---|---|---|---|
| Shares Bought | 0 | Average Price $-/Share | ||
| Shares Sold | 0 | Average Price $-/Share | ||
| Current Price $0.00 | Total Estimated Gain 0 % | |||
Top Ranked Articles
- 1
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
